Patient outcomes and experiences of going flat
https://www.facingourrisk.org/XRAY/going-flat
Full article: https://doi.org/10.1245/s10434-020-09448-9
Some patients with early-stage breast cancer or those considering risk-reducing surgery may choose mastectomy without reconstruction. This is often referred to as “going flat.” The results of this study suggest that surgeons play a significant role in supporting a patient’s decision to go flat. (3/23/2021)
Este artículo está disponible en español.
Questions To Ask Your Health Care Provider
- Is going flat an option for me?
- What are the risks and benefits of going flat?
- What are the risks and benefits of having breast reconstruction?
- What are the risks and benefits of having breast-conserving surgery?
- Am I a candidate for an aesthetic flat closure?
- Are there resources that you can recommend if I choose to go flat?
- If I go flat, are breast implants or other reconstructive procedures an option later in life?
Open Clinical Trials
The following studies are related to mastectomy and breast reconstruction.
- NCT05720039: Nipple-Sparing Mastectomy With Immediate Implant-Based Reconstruction for Women With Early-Stage Breast Cancer. This study will compare robotic-assisted nipple-sparing mastectomy (NSM) to standard surgery NSM for women with early-stage breast cancer.
- NCT02918474: Decision-Making Tool in Supporting Decision-Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer. This trial studies the acceptability and usefulness of a tool that supports decision-making for contralateral prophylactic mastectomy in patients with newly diagnosed breast cancer.
- NCT05020574: Microbiome and Association With Implant Infections. This study is looking at whether people with high amounts of certain types of bacteria are more likely to develop tissue expander-related infections than those with lower amounts of bacteria.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.